Central Pacific Bank - Trust Division’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.99M Sell
4,906
-122
-2% -$46.6K 0.21% 115
2026
Q2
$2M Buy
5,028
+38
+0.8% +$16.6K 0.2% 123
2026
Q1
$2.3M Buy
4,990
+604
+14% +$306K 0.29% 88
2025
Q4
$2.48M Buy
4,386
+21
+0.5% +$11.2K 0.3% 82
2025
Q3
$1.95M Sell
4,365
-2,309
-35% -$1.11M 0.24% 108
2025
Q2
$3.63M Sell
6,674
-24
-0.4% -$12.5K 0.46% 54
2025
Q1
$3.32M Buy
6,698
+207
+3% +$114K 0.46% 48
2024
Q4
$3.39M Sell
6,491
-172
-3% -$89.6K 0.44% 45
2024
Q3
$3.27M Sell
6,663
-15
-0.2% -$6.98K 0.41% 54
2024
Q2
$2.97M Sell
6,678
-148
-2% -$58.9K 0.35% 58
2024
Q1
$2.7M Buy
+6,826
New +$2.58M 0.33% 62

Other funds holding ISRG

Central Pacific Bank - Trust Division's ISRG Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Intuitive Surgical (ISRG) stake by 2.4% in Q3 2026, selling an estimated $46.6K and leaving 4,906 shares worth $1.99M. The position accounts for 0.21% of the portfolio, ranked #115.

Central Pacific Bank - Trust Division first reported a position in ISRG in Q1 2024 and has held it in 11 quarters since. The position peaked at $3.63M in Q2 2025. 28 funds tracked by Wall St. Rank hold ISRG as of Q3 2026.

  • Central Pacific Bank - Trust Division held 4,906 shares of Intuitive Surgical worth $1.99M as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 122 Intuitive Surgical shares in Q3 2026, an estimated $46.6K.
  • Intuitive Surgical made up 0.21% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #115 holding.
  • Central Pacific Bank - Trust Division first reported a position in Intuitive Surgical in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Intuitive Surgical position peaked at $3.63M in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.